BIIB vs GYRO · P/E 21, rev $9.89B vs P/E 46, rev $1.8M
Biogen Inc (BIIB) versus Gyrodyne Company of America Inc (GYRO) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Gyrodyne Company of America Inc (GYRO) is a real estate services company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported GYRO revenue for 2015-08-31 was $1.8M. Net income was -$2.5M. Revenue was down 34.8% from 2014-12-31 to 2015-08-31. GYRO currently screens at market cap $20.0M and trailing P/E 45.5.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. GYRO currently screens at market cap $20.0M and trailing P/E 45.5.
Not investment advice. Open the BIIB and GYRO stock pages for the full models.
Not investment advice.